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Paravertebral blocks and enhanced recovery 
after surgery protocols in breast reconstructive 
surgery: patient selection and perspectives
Rajiv P Parikh 
Terence M Myckatyn
Department of Surgery, Division of 
Plastic and Reconstructive Surgery,  
Washington University School of 
Medicine, St Louis, MO, USA
Abstract: The management of postoperative pain is of critical importance for women under-
going breast reconstruction after surgical treatment for breast cancer. Mitigating postoperative 
pain can improve health-related quality of life, reduce health care resource utilization and costs, 
and minimize perioperative opiate use. Multimodal analgesia pain management strategies with 
nonopioid analgesics have improved the value of surgical care in patients undergoing various 
operations but have only recently been reported in reconstructive breast surgery. Regional anes-
thesia techniques, with paravertebral blocks (PVBs) and transversus abdominis plane (TAP) 
blocks, and enhanced recovery after surgery (ERAS) pathways have been increasingly utilized 
in opioid-sparing multimodal analgesia protocols for women undergoing breast reconstruction. 
The objectives of this review are to 1) comprehensively review regional anesthesia techniques 
in breast reconstruction, 2) outline important components of ERAS protocols in breast recon-
struction, and 3) provide evidence-based recommendations regarding each intervention included 
in these protocols. The authors searched across six databases to identify relevant articles. For 
each perioperative intervention included in the ERAS protocols, the literature was exhaustively 
reviewed and evidence-based recommendations were generated using the Grading of Recom-
mendations, Assessment, Development, and Evaluation system methodology. This study provides 
a comprehensive evidence-based review of interventions to optimize perioperative care and 
postoperative pain control in breast reconstruction. Incorporating evidence-based interven-
tions into future ERAS protocols is essential to ensure high value care in breast reconstruction.
Keywords: enhanced recovery after surgery, ERAS, postmastectomy breast reconstruction, 
autologous flap, breast implant
Introduction
Breast reconstruction after surgical treatment for breast cancer has the potential to 
significantly improve patients’ health-related quality of life.1–7 Although most women 
report greater satisfaction with appearance and improved physical, psychosocial, and 
sexual well-being following breast reconstruction, the management of postoperative pain 
remains challenging. Inadequate postoperative pain control contributes to unnecessary 
health care resource utilization while exacerbating costs and hindering patient recovery. 
This is true for both implant-based (prosthetic) and microvascular (autologous) breast 
reconstruction techniques. Nearly one-half of patients undergoing breast reconstruction 
experience postoperative pain syndromes.8,9 Inadequately controlled acute postoperative 
pain is associated with an increased likelihood of developing persistent postsurgical 
pain, which reduces the quality of life.8–12 Additionally, poorly controlled pain may result 
in a prolonged opioid dependency, contributing to the ongoing opioid epidemic in the 
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United States.13,14 Furthermore, postoperative pain negatively 
impacts the quality of recovery (QoR) and  satisfaction.15–17 
There is evidence that a decrease in QoR secondary to pain 
can prolong hospital stay, delay return to normal daily living, 
and reduce the quality of life.15–19 Thus, opioid-sparing anal-
gesic strategies to improve postoperative pain control, reduce 
length of stay (LOS), and minimize resource utilization are 
essential to improve the overall quality and value of care for 
patients undergoing breast reconstruction.20–22
Recently, there have been a few interventions introduced 
that have promise in optimizing pain control and postopera-
tive recovery for women with breast cancer undergoing breast 
reconstruction. The most prevalent of these are regional 
anesthesia techniques, including paravertebral blocks (PVBs) 
and transversus abdominis plane (TAP) blocks, and evidence-
based multimodal perioperative management approaches, 
referred to as Enhanced Recovery after Surgery (ERAS) 
protocols. The purported strengths of these interventions are 
that they significantly improve the value of surgical care by 
enhancing postoperative recovery.23–27 ERAS protocols utilize 
evidence-based recommendations to standardize perioperative 
care.28 Although widely adopted in various surgical disci-
plines, there was minimal literature on opioid-sparing mul-
timodal analgesia strategies in reconstructive breast surgery 
until recently.29 As a result, perioperative approaches have 
traditionally been based on individual experience and differed 
tremendously across institutions, potentially contributing to 
variations in system-wide quality and unnecessary resource 
utilization. Therefore, the goals of this article are to 1) com-
prehensively review regional anesthesia techniques in breast 
reconstruction, 2) outline important components of ERAS 
protocols in breast reconstruction, and 3) provide evidence-
based recommendations regarding all perioperative interven-
tions aimed at enhancing recovery in breast reconstruction.
Methods
This study was conducted in the following two stages: 1) 
comprehensive review of regional analgesic techniques and 
ERAS protocols in breast reconstruction and 2) literature 
review and generation of evidence-based recommendations 
for all interventions included in ERAS protocols for breast 
reconstruction. The authors followed the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines throughout this investigation.30,31
Review of regional analgesia techniques and 
ERAS protocols in breast reconstruction
To identify regional analgesia and ERAS protocols, we 
searched the Ovid MEDLINE, EMBASE, SCOPUS, Web 
of Science, Cochrane Central Register of Controlled Trials, 
and ClinicalTrials.gov databases from January 1990 through 
October 2017 using strategies designed by a medical librarian 
for the concepts of breast reconstruction, regional analgesia, 
perioperative care or fast track or enhanced recovery, and 
LOS, postoperative complications, or pain. All results were 
exported to EndNote, and duplicate citations were removed. 
References were then hand-searched, and relevant articles 
were retrieved. All studies reporting patients undergoing 
breast reconstruction in an ERAS protocol or with regional 
analgesia techniques were eligible for inclusion. Articles in 
all languages were considered. A study was excluded if full 
text could not be obtained.
Evidence-based recommendations for 
ERAS protocol items
In the second stage, we performed a literature review of 
each intervention included in the previously identified 
ERAS protocols with search parameters for [X] and breast 
reconstruction, where X = specific intervention in the ERAS 
protocol. For each item, searches were performed to identify 
the best available evidence, with priority given to meta-
analyses, systematic reviews, and randomized-controlled 
trials (RCTs). In the absence of high-quality evidence spe-
cific to breast reconstruction, we included nonrandomized 
observational studies and/or extrapolated evidence from the 
surgical literature. Consistent with other studies, we used the 
Grading of Recommendations, Assessment, Development, 
and Evaluation (GRADE) system to appraise the overall 
quality of evidence for each intervention and to assign a 
level of strength to each recommendation.32–36 The GRADE 
system is widely adopted, and the preferred methodology of 
The Cochrane Collaboration and the Agency for Healthcare 
Research and Quality (AHRQ) for grading clinical evidence 
and developing recommendations for clinical practice is 
used.37 The GRADE approach classifies recommendations 
into two levels, such as strong (Grade 1) and weak (Grade 2), 
and then subclassifies each grade into three categories based 
on the quality of evidence (A = high quality, B = moderate 
quality, and C = low quality).38–40 The strength of recom-
mendation is primarily influenced by the tradeoff between 
the benefits, risks, and burdens of an intervention and by the 
quality of the evidence available.
Regional analgesic techniques in 
breast reconstruction
Regional anesthesia techniques are utilized across surgical 
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Pain management in breast reconstruction
acute and chronic postoperative pain, opiate use, and LOS 
for various surgical procedures.41 In reconstructive breast 
surgery, the two most common techniques for regional 
anesthesia are PVBs and TAP blocks. PVBs are utilized in 
both prosthetic and autologous breast reconstruction proce-
dures, whereas TAP blocks only have utility in abdominally 
based autologous breast reconstruction procedures such as 
deep inferior epigastric artery perforator (DIEP) flaps and 
transverse rectus abdominis myocutaneous (TRAM) flaps. 
Traditionally, regional blocks or infusions were performed 
with bupivacaine, which has a duration of action between 8 
and 12 hours. However, recently, several groups have shifted 
toward using liposomal bupivacaine, which has a duration of 
action ranging from 72 to 96 hours.42 Although comparative 
studies evaluating cost and outcomes between bupivacaine 
and liposomal bupivacaine are still needed, there is prelimi-
nary evidence to demonstrate the efficacy and merit the use 
of liposomal bupivacaine in reconstructive breast surgery.43
TAP blocks
TAP blocks were initially introduced in the literature in 
the early 2000s and have subsequently gained widespread 
acceptance as an effective technique for regional anesthesia 
in various abdominally based surgical operations.44,45 In 
abdominally based autologous breast reconstruction proce-
dures, TAP blocks were first reported as having efficacy for 
improving pain control and reducing opiate requirements by 
Hivelin et al46 in 2011. To date, there is evidence from one 
RCT, two prospective cohort studies, and two retrospective 
studies demonstrating that TAP blocks are safe and signifi-
cantly reduce postoperative opioid use in abdominally based 
autologous breast reconstruction.46–50 There are several excel-
lent articles that detail the relevant anatomy and technical 
components of performing a TAP block.51,52 Briefly, TAP 
blocks involve anesthetizing the sensory innervation to the 
anterior abdominal wall, which is traditionally considered 
to be derived from the T6-L1 nerves from the anterior rami 
of the thoracolumbar spinal nerves.51,52 The lumbar triangle 
of Petit is often used as the primary landmark to local-
ize the injection to the plane between the internal oblique 
musculature and the transversus abdominis musculature. In 
autologous breast reconstruction, this block is performed 
under direct visualization following flap harvest and prior 
to closure of the abdominal donor site. A blunt tip injection 
cannula is inserted into the TAP and local anesthetic in the 
form of bupivacaine or liposomal bupivacaine is injected. 
Alternatively, a catheter can also be introduced in the plane 
and redosed periodically in the perioperative period.47,48 For 
bilateral procedures, bilateral blocks are performed.
PVBs
There is considerable evidence supporting the use of PVBs 
in breast surgery. In a meta-analysis of 15 RCTs in breast 
cancer surgery, PVBs were determined to be effective at 
reducing postoperative pain and hospital LOS.53 In recon-
structive breast surgery, there is literature to support the use 
of PVBs in both prosthetic breast reconstruction and autolo-
gous breast reconstruction procedures. A recent prospective 
study by Parikh et al54 demonstrated a significant reduction 
in postoperative pain and LOS for women with breast cancer 
undergoing postmastectomy abdominally based autologous 
breast reconstruction with a PVB compared to women 
who did not receive a PVB. In a follow-up study from the 
same group, the authors also reported a reduction in opiate 
medication requirements for patients undergoing autologous 
breast reconstruction with use of a PVB compared to patients 
undergoing autologous breast reconstruction without a 
PVB.55 Of importance, the use of PVBs did not compromise 
intraoperative perfusion or change fluid requirements in this 
cohort. The value of PVBs is not confined to abdominally 
based breast reconstruction. In 2016, Unkart et al56 reported 
their experience with PVBs for patients undergoing breast 
reconstruction with latissimus dorsi autologous flaps. In pros-
thetic breast reconstruction, there are several retrospective 
cohort studies and one RCT that similarly confirm the value 
of PVBs versus general anesthesia alone. Coopey et al57 and 
Fahy et al58 independently demonstrated reductions in LOS, 
perioperative opiate use, and postoperative pain for patients 
undergoing immediate prosthetic breast reconstruction with 
a PVB compared to patients who did not receive a PVB. 
This reduction in perioperative opiate use was subsequently 
confirmed in a 2015 report by Glissmeyer et al,59 where the 
authors reported that morphine equivalents were significantly 
lower in the cohort of patients who received a PVB in post-
mastectomy breast reconstruction compared to the cohort 
of patients who did not. In 2016, Wolf et al reported results 
from the first prospective RCT of PVBs in prosthetic breast 
reconstruction. In a total of 74 patients (35 who received a 
PVB and 34 in the control group), the authors demonstrated 
that patients who received a PVB, compared to patients who 
did not, required significantly less opiates intraoperatively 
and postoperatively, had lower pain scores postoperatively, 
and required less antiemetic medications perioperatively.60 
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with minimal risk for complications, as confirmed in a 2016 
report of 856 patients undergoing 1427 PVBs for regional 
anesthesia in postmastectomy prosthetic reconstructive 
breast surgery procedures where the complication rate was 
<1.0%.61 Similar to TAP blocks, there are excellent articles 
that detail the anatomical and technical considerations for 
performing PVBs.61,62 Briefly, our preferred approach is to 
inject 15–20 mL of 0.5% bupivacaine (bilateral for bilateral 
procedures) at the T2–T4 paravertebral spaces under ultra-
sound guidance in the immediate preoperative setting.54,55 
These procedures are performed by fellowship trained anes-
thesiologists on a dedicated regional block team.
Recommendation: There is moderate-quality evidence to 
support the inclusion of regional analgesic techniques with 
TAP blocks and PVBs in ERAS protocols for microvascular 
breast reconstruction and PVBs for prosthetic breast recon-
struction (Grade 1B).
ERAS protocols in breast 
reconstruction
Following review, there were five nonrandomized studies 
from four different institutions that evaluated ERAS protocols 
in breast reconstruction (Table 1).63–67 In total, studies evalu-
ated 49 patients undergoing prosthetic reconstruction and 661 
Table 1 Characteristics of studies comparing breast reconstruction outcomes for patients in an ERAS protocol to conventional care




in usual care 
protocol, n
Perioperative interventions 




USA 2015 Retrospective 
cohort
49 51 Preoperative education; fasting only 
2 hours for clear liquids prior to 
surgery; antimicrobial prophylaxis; 
multimodal analgesia with opiates, 
NSAIDs, acetaminophen, gabapentin 
+ TAP blocks with liposomal 
bupivacaine; euvolemia fluid 
management; antiemetics; oral feeding 
on POD 0; early ambulation; urinary 
catheter removal POD 1
Length of stay, 
total opiate use, 






Denmark 2015 Case–control 177 277 Preoperative education; antimicrobial 
prophylaxis; multimodal analgesia 
with opiates (on request), NSAIDs 
and acetaminophen; early ambulation; 
urinary catheter removal POD 1





Denmark 2016 Retrospective 
cohort
16 N/A Preoperative education; antimicrobial 
prophylaxis; multimodal analgesia 
with opiates (on request), NSAIDs, 
acetaminophen, and gabapentin; 
minimally invasive approach (DIEP 
flaps only); oral feeding on POD 1; 
early ambulation; urinary catheter 
removal POD 1





USA 2017 Retrospective 
cohort
42 49 Preoperative education; fasting only 
2 hours for clear liquids prior to 
surgery; multimodal analgesia with 
opiates, NSAIDs (IV ketorolac), and 
acetaminophen + TAP blocks with 
liposomal bupivacaine; goal-directed 
fluid management; antiemetics; oral 
feeding on POD 1; early ambulation; 
urinary catheter removal POD 1
Length of stay, 
total opiate use, 






Canada 2017 Retrospective 
cohort
29 29 Preoperative education; fasting only 
3 hours for clear liquids prior to 
surgery; multimodal analgesia with 
opiates, celecoxib/NSAIDs, and 
acetaminophen + local nerve blocks 
with bupivacaine
Length of stay, 




Abbreviations: DIEP, deep inferior epigastric artery perforator; ERAS, enhanced recovery after surgery; NSAIDs, nonsteroidal anti-inflammatory drugs; POD, postoperative 
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Pain management in breast reconstruction
patients undergoing 783 microvascular flaps for autologous 
reconstruction. Of them, 29 patients undergoing prosthetic 
reconstruction and 284 patients undergoing 345 flaps were 
treated in an ERAS protocol, whereas 29 patients undergo-
ing prosthetic reconstruction and 377 patients undergoing 
438 flaps were treated with conventional care. There were 
two studies from the same group: the first study, published 
in 2015, compared an ERAS protocol with conventional 
care and the second study, published in 2016, reported on 
16 patients in a modified ERAS protocol, which was then 
compared with their previously published data on patients 
in the first version of the ERAS protocol.65,66 There was 
substantial heterogeneity between the treatment protocols, 
patient groups, comorbidities reported, and postoperative 
outcomes measured; therefore, quantitative analyses across 
studies were not feasible. In regard to outcomes reported, all 
studies reported LOS, but only three studies reported postop-
erative pain scores, two studies reported opiate use, and three 
studies reported systemic complications. No study reported 
cost outcomes. Additionally, data on relevant covariates or 
potential confounders were inconsistently reported.
Evidence-based recommendations 
for components of ERAS protocols
Preoperative interventions
Patient education/counseling
Preoperative patient education and counseling are essential to 
patient-centered care, one of the key domains of high-quality 
health care.68 Patient education and counseling should address 
patients’ expectations, include a comprehensive discussion 
of the risks and benefits of different treatment options, assess 
patients’ understanding of their expected perioperative 
course, and involve patients in the decision-making pro-
cess.69,70 In breast reconstruction, several studies, utilizing 
the BREAST-Q patient-reported outcome measure, have 
shown a positive association between patient’s satisfaction 
with preoperative information and postoperative outcome.71,72 
Additionally, Sheehan et al73 and Zhong et al74 independently 
demonstrated that lower satisfaction with preparatory infor-
mation is associated with an increased likelihood of regret 
following breast reconstruction. When expanded across 
surgical specialties, there is also evidence that preoperative 
education is an independent predictor of reduced LOS in 
ERAS protocols.75–77
Recommendation: Preoperative education is integral 
to patient-centered care and has the potential to improve 
postoperative patient-reported outcomes while minimizing 
decision regret. The impact of patient education on LOS 
has not been examined in breast reconstruction; however, 
there are minimal risks associated with this intervention. 
Consequently, we strongly recommend ERAS protocols in 
breast reconstruction that incorporated preoperative educa-
tion and counseling, ideally in a shared decision-making 
model (Grade 1B).
Fasting, nutrition, and carbohydrate loading
In two of the ERAS protocols for breast reconstruction, 
preoperative fasting from the intake of clear liquids for at 
least 2 hours prior to surgery was included in the treatment 
pathway, whereas one study recommended at least 3 hours 
of fasting.63,64,67 For decades, preoperative fasting was rec-
ommended with “NPO after midnight” in an effort to mini-
mize the risk of pulmonary aspiration by decreasing gastric 
 volume.78 However, over the last several years, this dogma 
has been challenged by a multitude of studies demonstrating 
preoperative fasting from the intake of clear fluids for 2 hours 
and from the intake of solids for 6 hours to be optimal. A 2017 
meta-analysis of RCTs demonstrated a lower risk of aspira-
tion for patients with clear liquid intake up to 2 hours prior to 
surgery versus traditional fasting (>4 hours).79 Furthermore, 
prior systematic reviews concluded that preoperative fasting 
to 6 hours for solids is safe.80 The primary concern with pro-
longed fasting is exacerbation of the surgical stress response, 
which constitutes a coordinated reaction to surgical injury.27,81 
Ultimately, prolonged catabolism from fasting combined with 
the surgical stress response can potentiate hyperglycemia, 
insulin resistance, hyperthermia, immunosuppression, and 
muscle loss in the perioperative period, potentially contribut-
ing to adverse outcomes and delayed recovery.26,27 Therefore, 
the goal with perioperative nutritional management is to 
mitigate these effects.
In addition to changing fasting guidelines, there is consid-
erable evidence from meta-analyses, systematic reviews, and 
RCTs demonstrating the intake of carbohydrate-rich liquids, 
ie, carbohydrate loading, prior to elective surgery, reduces 
postoperative insulin resistance and hyperglycemia, mini-
mizes muscle loss, and shortens LOS.79,80,82–88 Furthermore, 
several RCTs establish clear liquid intake and carbohydrate 
loading up to 2 hours before a procedure improves patients’ 
subjective well-being by reducing thirst and hunger.79,80,86,89–91 
Although there are no specific studies in breast reconstruc-
tion, evidence-based recommendations can be adapted from 
these studies in the elective surgical population.
Recommendation: We recommend minimizing preopera-
tive fasting to only 2 hours for clear liquids and 6 hours for 
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carbohydrate loading via oral liquid intake up to 2 hours 
prior to surgery to mitigate adverse effects associated with 
the surgical stress response (Grade 1A).
Antimicrobial prophylaxis
All ERAS protocols included preoperative antibiotic use. In 
breast reconstruction, evidence for perioperative antibiotics 
for the prevention of surgical site infection (SSI) is largely 
based on studies in the prosthetic population; data on antibiotic 
use in microvascular breast reconstruction are limited. A prior 
survey of members of the American Society for Reconstruc-
tive Microsurgery (ASRM) revealed consensus agreement 
regarding preoperative administration of antibiotics within 
1 hour prior to microvascular breast reconstruction; however, 
no consensus was present on the optimal duration of antibiotic 
administration.92 The practice of administering preoperative 
antibiotics within 60 minutes of incision is supported by con-
siderable high-quality evidence, albeit not specific to breast 
reconstruction, including a 2014 Cochrane review of RCTs, 
and recommended by major national organizations, including 
Centers for Disease Control and Prevention (CDC), the Sur-
gical Care Improvement Project (SCIP), and the AHRQ.93–97 
What is less clear is the optimal duration of antibiotics. SCIP 
and CDC guidelines recommend a short duration (<24 hours) 
of prophylaxis.94,95,97 There are two retrospective studies com-
paring patients receiving 24 versus >24 hours of antimicrobial 
prophylaxis in microvascular breast reconstruction.98,99 These 
studies showed no reduction in overall incidence of SSI for 
patients receiving antibiotics >24 hours. This is also supported 
by systematic reviews regarding the duration of prophylactic 
antibiotic use in prosthetic breast reconstruction, which pre-
sumably has an equal or higher intrinsic risk of SSI due to 
the placement of an implant.100,101
One of the ERAS protocols included antiseptic bathing 
for antimicrobial prophylaxis. Preoperative bathing and 
postoperative bathing with skin antiseptics are often recom-
mended in procedures involving the placement of a prosthe-
sis; however, the prevalence of this practice is unclear.102–104 A 
2015 Cochrane review and a 2017 meta-analysis separately 
confirmed that there is no clear evidence of benefit for show-
ering/bathing with antiseptic solution compared to usual wash 
products prior to clean surgeries.105,106
Recommendation: All patients undergoing breast recon-
struction should receive preoperative antibiotics within 
1 hour of incision. There is no documented benefit to pro-
longed antimicrobial prophylaxis; therefore, we recommend 
adherence to SCIP and CDC guidelines for administering 
only 24 hours of antibiotics (Grade 1A). There is no proven 
benefit for preoperative showering/bathing with antiseptic 
solution; thus, we recommend patients follow usual bathing 
practices prior to surgery (Grade 1A).
Intraoperative management
Preemptive analgesia and PVBs
The management of postoperative pain with multimodal 
therapy is a key component of ERAS protocols. Multimodal 
protocols are presumed to be effective because they address 
different pain mechanisms to reduce acute postoperative pain, 
which may subsequently blunt the development of chronic 
pain.27,107 ERAS protocols for breast reconstruction incorpo-
rated preemptive analgesia with opioid (at the discretion of the 
anesthesia provider) and nonopioid combinations of regional 
anesthesia blocks (2/5 studies), nonsteroidal anti-inflammatory 
drugs (NSAIDs) (4/5 studies), acetaminophen (5/5 studies), 
and/or gabapentin (4/5 studies). Regional anesthesia tech-
niques were previously discussed; NSAIDs, acetaminophen, 
and gabapentin are discussed in the postoperative management 
section. Local anesthetic techniques utilizing continuous infu-
sion pain catheters and regional anesthetic techniques utilizing 
peripheral nerve blocks are described in the literature. A meta-
analysis in 2013 demonstrated local anesthetic pain catheters 
at the donor site, either on top of the rectus sheath or under 
the rectus fascia, significantly decreased opioid use but only 
showed a trend toward reducing LOS, for patients undergoing 
microvascular breast reconstruction (MBR).108 Furthermore, 
two RCTs confirmed that continuous infusion catheters have 
no deleterious effect on flap perfusion or complications.109,110
Recommendation: There is moderate quality evidence 
to support the inclusion of local anesthetic techniques and 
preemptive analgesia in breast reconstruction (Grade 1B).
Perioperative hemodynamics: fluid management, 
vasopressors, and allogenic blood transfusions
Perioperative hemodynamics is more relevant to microvas-
cular breast reconstruction compared to prosthetic breast 
reconstruction. The goal of perioperative hemodynamic man-
agement in microvascular breast reconstruction is to maintain 
tissue perfusion and optimize blood flow for the flap.111 A 
majority of microsurgeons agree that avoiding intraoperative 
hypotension, often considered as a mean arterial pressure 
(MAP) of <65 mmHg, is critical to flap success and prefer 
some combination of intravenous fluids, blood products, and 
vasopressors to achieve this.112 Our understanding of fluid 
management has evolved recently, and most ERAS protocols 
advocate for either a balanced fluid approach ( emphasizing 
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Pain management in breast reconstruction
normal physiology and homeostasis) or a goal-directed 
fluid therapy (GDFT) (emphasizing optimal cardiac output 
and oxygen delivery to tissues to prevent hypoperfusion).113 
In microvascular breast reconstruction, there is evidence to 
support a focus on maintenance of a zero, or near zero, fluid 
balance. Data from two retrospective studies demonstrate 
that excessive underresuscitation contributes to an increased 
risk for adverse flap events.114,115 Similarly, retrospective stud-
ies have shown liberal fluid resuscitation or fluid overload 
increases flap complications in both breast reconstruction and 
other microvascular flap procedures.115–119 In the nonfree flap 
population, meta-analyses of RCTs reaffirm the value of bal-
anced fluid therapy in reducing perioperative complications 
and LOS.120,121 There are no studies evaluating GDFT, which 
uses hemodynamic monitoring to guide fluid management, 
in microvascular breast reconstruction. However, multiple 
meta-analyses on GDFT in surgical patients demonstrate 
reductions in complications and LOS compared to standard 
or liberal fluid resuscitation models.122–129 There are no studies 
comparing GDFT with balanced fluid therapy.
Although vasopressors were initially presumed to have 
devastating effects on free flap success, recent evidence has 
not corroborated these fears. A 2014 systematic review of 
retrospective studies showed no consistent effects on flap 
perfusion or flap complications.130 Subsequent to that publi-
cation, a retrospective cohort study of 682 patients and 1039 
flaps also failed to demonstrate an increased risk of throm-
botic events or flap loss in patients receiving vasopressors.131
In contrast to vasopressors and a balanced fluid approach, 
there is evidence suggesting that perioperative allogenic red 
blood cell transfusions in microvascular breast reconstruction 
are associated with an increased rate of postoperative compli-
cations and additional resource utilization. Six retrospective 
studies, all published after 2011, concluded that perioperative 
transfusions increase postoperative complications, prolong 
LOS, and incur additional costs; therefore, restrictive transfu-
sion strategies (avoid transfusions in patients with hemoglo-
bin thresholds >7 g/dL) are now advocated.132–138
Recommendation: Perioperative fluid management should 
follow principles of balanced fluid therapy or GDFT and 
avoid underresuscitation and/or fluid overload (Grade 1A). 
Vasopressors may be used as an adjunct to intravenous fluids 
to avoid intraoperative hypotension and maintain hemody-
namic stability; to date, human clinical studies have not 
demonstrated adverse complications with vasopressor use in 
microvascular breast reconstruction, albeit the existing data 
are of low quality (Grade 2C). We recommend a restrictive 
strategy for allogenic transfusions to minimize postoperative 
complications and avoid prolonged LOS (Grade 1C).
Minimally invasive operative techniques (in 
autologous breast reconstruction)
Muscle-sparing procedures (donor-site)
Minimizing the invasiveness of surgical procedures is a key 
component of ERAS protocols in different specialties. All 
patients treated in the included ERAS protocols for micro-
vascular breast reconstruction underwent either a unilateral 
procedure or a bilateral procedure utilizing free TRAM 
(FTRAM), muscle-sparing TRAM (MS-TRAM), or DIEP 
flaps; there were no superficial inferior epigastric artery 
(SIEA) flaps reported. SIEA and DIEP flaps, which theoreti-
cally preserve the abdominal wall, would constitute the spec-
trum of “minimally invasive” surgery when compared with 
FTRAM or MS-TRAM flaps or pedicled flaps in autologous 
breast reconstruction. In regard to acute recovery, a majority 
of the data compares DIEP flaps with TRAM flaps (with MS-
TRAM and FTRAM often combined into one group). There 
are three retrospective studies demonstrating that mean LOS 
is shorter in patients undergoing DIEP flaps than in patients 
undergoing TRAM flaps.139–141 There is also a single prospec-
tive cohort study demonstrating significantly shorter LOS for 
SIEA flaps compared with DIEP flaps; however, this study 
is limited by inadequate sample size and the lack of control 
for comorbidities.142 In regard to long-term postoperative 
function, there are multiple meta-analyses of nonrandomized 
observational studies comparing donor-site morbidity and 
abdominal wall function in patients undergoing MBR with 
DIEP, SIEA, or TRAM flaps.143–146 These studies demonstrate 
that SIEA and DIEP flaps reduce donor-site morbidity, 
including abdominal bulge or hernia, compared to TRAM 
flaps but may increase the risk of flap-related complications. 
However, there are several methodological limitations to the 
studies included in these meta-analyses, which make them 
highly susceptible to bias. Interestingly, a recent multicenter 
study in North America did not find significant differences 
in patient-reported outcomes of abdominal well-being or 
morbidity when comparing DIEP flaps with TRAM flaps.147
Recommendation: Surgeons must consider the benefits 
of potentially reduced abdominal wall morbidity against the 
potential risk of higher complications and the potential bur-
dens of increased operative time and complexity associated 
with SIEA and DIEP flaps. We suggest autologous breast 
reconstruction be performed with DIEP flaps whenever fea-





























































Powered by TCPDF (www.tcpdf.org)
                               1 / 1





MS-TRAM, FTRAM, or pedicled autologous flap, which is 
most often dictated by patients’ anatomy and characteristics 
(Grade 2B).
Rib-sparing techniques (recipient site)
In addition to donor-site preservation, a less invasive 
approach to the recipient site is also advocated in the litera-
ture for microvascular breast reconstruction. The presumed 
benefit of a rib-sparing approach to internal mammary ves-
sel harvest is diminished chest wall morbidity, whereas the 
presumed disadvantages are complexity in patients with 
narrow intercostal spaces and limited exposure, which may 
lead to operative complications.148 To date, there is low-
quality evidence to support rib-sparing techniques. Seven 
retrospective studies have been published, most of which 
focus on the efficiency and safety of this technique.149–155 
Due to substantial heterogeneity, comparison across studies 
is limited. Only three studies included a comparison group 
(costochondral segment removed) and two of these compared 
postoperative pain, both demonstrating significantly reduced 
pain with rib preservation.151,153,154 In regard to complications, 
most studies had no comparison group but reported a low 
incidence of complications in line with acceptable published 
standards for breast reconstruction; however, one study did 
find a significantly greater incidence of fat necrosis with a 
rib-sparing approach.154
Recommendation: There is low-quality evidence to 
support rib-sparing techniques in microvascular breast 
reconstruction, and substantial uncertainty is present in the 
estimates of benefits, risks, and burdens associated with this 
technique. Given this, we can only formulate a very weak rec-
ommendation that surgeons perform rib-sparing techniques 
in patients with suitably wide intercostal spaces; however, 
other alternatives may be equally reasonable (Grade 2C).
Prevention of postoperative nausea and vomiting 
(PONV)
Avoidance of PONV is frequently identified by patients as 
their top priority in the immediate postoperative recovery 
period; therefore, the American Society of Anesthesiolo-
gists (ASA) recommends prophylaxis for PONV, in addition 
to minimize opiate use, in the perioperative period.156–159 
There are many agents with antiemetic effects; however, 
the best evidence supports 5-HT3 receptor antagonists (eg, 
ondansetron), dexamethasone, and transdermal scopolamine. 
Data from recent meta-analyses indicate that 5-HT3 receptor 
antagonists, dexamethasone, and scopolamine are indepen-
dently effective at reducing PONV and the need for rescue 
antiemetics when administered prophylactically.159–161 There 
are also several RCTs, comparing combination prophylaxis 
with multiple agents versus single-agent prophylaxis that 
demonstrate a benefit to combination therapy; however, vari-
ous combinations used and differences in patient populations 
precluded pooled analyses.159,162–166
Recommendation: We recommend pharmacological pro-
phylaxis with a combination of antiemetic agents to prevent 
PONV and limit the need for rescue treatment (Grade 1A).
Postoperative management
Postoperative analgesia
Minimizing the opiate use is an essential goal in any ERAS 
protocol. There is considerable support in the literature for 
incorporating NSAIDs, including intravenous ketorolac, 
into multimodal analgesia protocols. A Cochrane review of 
72 RCTs demonstrated that NSAIDs significantly reduce 
postoperative pain compared to placebo.167 Data from three 
other meta-analyses also confirm NSAIDs, as a part of mul-
timodal therapy, reduce postoperative pain, and minimize 
some adverse effects, including PONV, of opiates in the 
postoperative period.168–170 In regard to ketorolac, a meta-
analysis of 13 RCTs in a diverse group of surgical patients 
found that ketorolac significantly reduced postoperative pain, 
opioid consumption, and PONV.171 Recently, Afonso et al63 
demonstrated that the addition of intravenous ketorolac to 
liposomal bupivacaine TAP blocks significantly reduced 
opioid consumption compared to TAP blocks alone in patients 
undergoing microvascular breast reconstruction. These find-
ings support a prior retrospective cohort study that found 
ketorolac, as an adjunct treatment, reducing opiate use in 
TRAM flap breast reconstruction.172 Additionally, bleeding 
concerns with the use of ketorolac are not substantiated by 
the literature, for either breast reconstruction or surgical 
procedures in general.63,170,172,173
In addition to NSAIDs, acetaminophen has been sug-
gested as an adjunct to perioperative pain management 
protocols in breast reconstruction. A Cochrane review of 51 
RCTs demonstrated that acetaminophen use, compared to 
placebo, significantly reduced postoperative pain in surgical 
patients.174 Furthermore, a recent systematic review con-
cluded that a combination of acetaminophen and NSAIDs 
offers superior analgesia when compared with either drug 
alone, lending additional support to the concept of multi-
modal analgesia protocols.175
Similar to NSAIDs and acetaminophen, gabapentin is 
frequently included in ERAS protocols, with the presumed 
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Pain management in breast reconstruction
 sensitization.176 There are no studies evaluating the inde-
pendent effect of gabapentin on postoperative pain in breast 
reconstruction; however, multiple meta-analyses indicate that 
gabapentin has both a significant analgesic and an opioid 
sparing effect in surgical patients.176–179
Recommendation: Minimizing the opiate use and post-
operative pain is an essential goal of multimodal periopera-
tive care protocols. While minimal direct evidence exists in 
breast reconstruction, sufficient high-quality evidence may be 
extrapolated to support the inclusion of NSAIDs (ie, ketoro-
lac), acetaminophen, and gabapentin in ERAS protocols to 
reduce postoperative pain and opiate use (Grade 1A).
Early ambulation and functional recovery
All of the ERAS protocols included ambulation as a criterion 
for discharge, with early mobilization at postoperative day 
(POD) 1 emphasized. There are no studies that evaluate the 
independent impact of early ambulation on postoperative 
outcomes in breast reconstruction and limited studies in the 
broader surgical literature. A recent systematic review con-
cluded that there may be some benefit to accelerate bowel 
function and reduce hospital LOS with early mobilization in 
the abdominal and thoracic surgical populations; however, the 
poor methodological quality of included studies and inconsis-
tencies in reporting of outcomes made it difficult to draw any 
firm conclusions.180 The primary proposed benefit for early 
mobilization is the absence of prolonged immobilization, 
which is known to be associated with adverse events, includ-
ing venous thromboembolism, pulmonary deconditioning, 
and muscle weakness.181,182 The risks of early ambulation are 
unclear. If patients avoid significant flexion/extension at the 
waist, it is hard to identify a theoretical premise for how early 
ambulation would potentiate flap or donor-site complica-
tions in abdominally based autologous breast reconstruction. 
Furthermore, the only burden of early mobilization is the 
requirement for physical therapy or nursing assistance until 
patients can ambulate independently; however, this require-
ment is likely present regardless of the date of ambulation.
Recommendation: We recommend early ambulation 
be included in ERAS protocols for breast reconstruction. 
While there is a lack of high-quality evidence, the potential 
benefits appear to outweigh the risks and burdens for early 
mobilization (Grade 1C).
Timing of urinary catheter removal
Urinary catheter placement is significantly more common 
for lengthy autologous breast reconstruction procedures 
compared to prosthetic procedures. In microvascular breast 
reconstruction, all patients typically require urinary catheter-
ization, given the length of surgery and need for resuscitative 
monitoring. The timing of catheter removal was a focus in the 
published ERAS protocols for microvascular breast recon-
struction, with all including removal of urinary catheters at 
POD 1 as a protocol item. There is high-quality evidence, 
including meta-analyses and RCTs, from the nonmicrovas-
cular surgical literature to support this practice. In general, 
these studies have found lower rates of catheter-associated 
urinary tract infections and no significantly increased risk of 
recatheterization in patients who had early (POD 1) catheter 
removal.183–185
Recommendation: We recommend the removal of urinary 
catheters by POD 1, at the latest, in all patients undergoing 
breast reconstruction who do not require resuscitative moni-
toring (Grade 1A).
Timing of postoperative nutrition
Similar to the concepts of early mobilization and early 
removal of urinary catheters, surgeons in various disciplines 
have recommended early postoperative oral feeding (within 
24 hours of surgery) to enhance recovery by facilitating 
return to normal functioning. Traditionally, patients undergo-
ing prosthetic breast reconstruction were advanced to clear 
liquids and then a regular diet as tolerated immediately after 
surgery whereas patients undergoing microvascular breast 
reconstruction were kept NPO for at least 24 hours as a 
precaution in case where emergent return to the operating 
room was necessary. As detailed earlier, fasting from oral 
liquids does not alter anesthetic risks. Furthermore, given 
the low rate of flap complications requiring immediate take 
back, this practice of delayed oral intake is unnecessary. 
Although no direct evidence exists in breast reconstruction, 
there is considerable evidence from the broader surgical 
literature that early postoperative oral feeding is beneficial. 
Two recent meta-analyses, a 2014 Cochrane review of RCTs 
in abdominal gynecological surgery and a 2016 meta-analysis 
of 15 studies in gastrointestinal surgery, showed that early 
feeding was associated with shorter LOS, higher satisfac-
tion, and no increase in complications when compared with 
traditional timing.186,187
Recommendation: For prosthetic reconstruction, we 
recommend advancing patients’ diets as tolerated on POD 0. 
For microvascular breast reconstruction, we recommend 
postoperative oral feeding with clear liquids commencing 
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patient preference and comfort. In patients tolerating clear 
liquid intake, we advocate advancement to a regular diet on 
POD 1 (Grade 1B).
Discussion and future directions
Increasing health care costs have led to significant health care 
reforms and the advent of value-based and alternative pay-
ment models that incentivize value, efficiency, and quality in 
patient care.22,188 In these new paradigms, it is critical to pro-
vide high-quality care while minimizing resource utilization 
during an episode of care. In response, ERAS protocols have 
been proposed as potential strategies to improve the overall 
value of surgical care. While widely utilized in various surgi-
cal disciplines, few studies have evaluated ERAS protocols 
in breast reconstruction.64 In this study, we comprehensively 
reviewed the literature on ERAS protocols for breast recon-
struction and provided evidence-based recommendations for 
each perioperative intervention included in these protocols.
Although it is promising to start to find ERAS protocols 
utilized in breast reconstruction, there remains a paucity of 
high-quality evidence on the impact of these protocols. To 
date, only five retrospective studies have been published 
on ERAS protocols in breast reconstruction and there is a 
significant heterogeneity between these studies in regard 
to perioperative interventions included, patient groups, 
comorbidities reported, and outcomes measured. There 
is a substantial need for additional research endeavors on 
this topic. It is important that future efforts to develop and 
implement ERAS protocols in breast reconstruction follow 
evidence-based guidelines in development and clearly report 
the components of the protocol. Future RCTs or high-quality 
prospective cohort studies are a priority. For studies following 
a nonrandomized observational design, patient and treatment 
covariates should be reported and controlled for analytically. 
Furthermore, studies should report clinically meaningful 
outcomes in a standardized way to facilitate comparison. 
All studies should, at minimum, report LOS, postoperative 
opiate use, and patient-reported outcomes using validated 
measures, including QoR and health-related quality of life 
(BREAST-Q). Additionally, studies examining the cost-
effectiveness of ERAS protocols in breast reconstruction are 
needed to demonstrate if this intervention has value to the 
health care system. Finally, it would be valuable for studies 
to identify barriers and enablers to protocol implementation 
and provide a detailed description of the implementation 
process. Understanding these elements would allow different 
institutions to adapt evidence-based protocols to their local 
environment.
Conclusion
Optimizing the perioperative management of patients under-
going microvascular breast reconstruction by implementing 
ERAS protocols has the potential to improve postoperative 
pain control, enhance patient-centered outcomes, accelerate 
recovery, and minimize health care resource utilization. Insti-
tutions and surgeons aiming to optimize perioperative care 
in MBR should incorporate evidence-based interventions 
in the development of future ERAS protocols. Ultimately, 
following evidence-based recommendations, as delineated 
in this study, is integral to develop and implement treatment 
protocols with external validity that improve the quality and 
value of patient care.
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